testosterone undecanoate has been researched along with Aging in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 1 (4.55) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 9 (40.91) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, FF; Chen, YQ; Han, L; Liu, YP; Shang, YY; Song, M; Wang, ZH; Zhang, W; Zhong, M; Zhou, HM | 1 |
| Chen, FF; Chen, YQ; Li, Y; Li, YH; Liu, MH; Song, FQ; Song, M; Wang, ZH; Zhang, W; Zhao, J; Zhong, M | 1 |
| Bouloux, PM; Elbers, JM; Geurts, TB; Kaspers, MJ; Legros, JJ; Meehan, AG; Meuleman, EJ | 1 |
| Ho, C; Khoo, EM; Lee, BC; Lee, G; Lee, V; Low, WY; Ng, CJ; Tan, HM; Tan, WK; Tan, WS; Tong, SF | 1 |
| Dupuis, P; Gianatti, EJ; Grossmann, M; Hoermann, R; Zajac, JD | 1 |
| Bouloux, PM; Elbers, JM; Geurts, TB; Johnson-Levonas, AO; Kaspers, MJ; Legros, JJ; Meehan, AG; Meuleman, EJ | 1 |
| Almehmadi, Y; Nettleship, JE; Salman, M; Yassin, AA | 1 |
| Gooren, LJ; Haide, A; Saad, F; Yassin, A | 1 |
| Gooren, LJ; Haider, A; Padungtod, P; Saad, F | 1 |
| Andreotti, F; Crea, F; Ferrante, G | 1 |
| Khoo, EM; Lee, BC; Lee, EG; Lee, VK; Ng, CJ; Tan, HM; Tong, SF | 1 |
| Biagiotti, G; Caracciolo, S; Cavallini, G; Modenini, F; Vitali, G | 1 |
| Duschek, EJ; Gooren, LJ; Netelenbos, C | 1 |
| Saad, F; Yassin, AA | 1 |
| Karpishchenko, AI; Loran, OB; Mazurov, VI; Pecherskiĭ, AV; Pecherskiĭ, VI; Semiglazov, VF | 1 |
| Loran, OB; Mittenberg, AG; Pecherskiĭ, AV; Pecherskiĭ, VI; Semiglazov, VF; Vonskiĭ, MS | 1 |
| Morales, A; Nieschlag, E; Oettel, M; Schubert, M; Yassin, AA; Zitzmann, M | 1 |
| Ahn, TY; Hong, BS | 1 |
| Aleman, A; Bosch, JL; Emmelot-Vonk, MH; Grobbee, DE; Lock, TM; Nakhai Pour, HR; van der Schouw, YT; Verhaar, HJ | 1 |
| Matsumoto, AM; Page, S | 1 |
| Butler, GE; Hendry, M; Kelnar, CJ; Sellar, RE; Walker, RF; Wu, FC | 1 |
| Jacobelli, A | 1 |
2 review(s) available for testosterone undecanoate and Aging
| Article | Year |
|---|---|
Treatment of sexual dysfunction of hypogonadal patients with long-acting testosterone undecanoate (Nebido).
Topics: Aging; Delayed-Action Preparations; Erectile Dysfunction; Humans; Hypogonadism; Male; Testosterone; Testosterone Congeners | 2006 |
Recent trends in the treatment of testosterone deficiency syndrome.
Topics: Aging; Androgens; Body Composition; Drug Therapy, Combination; Hormone Replacement Therapy; Humans; Male; Muscle Strength; Osteoporosis; Phosphodiesterase Inhibitors; Piperazines; Purines; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Syndrome; Testosterone | 2007 |
9 trial(s) available for testosterone undecanoate and Aging
| Article | Year |
|---|---|
Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study.
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Aged, 80 and over; Aging; Body Composition; Bone Density; Deficiency Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Male; Middle Aged; Muscle Strength; Prospective Studies; Reference Values; Risk Assessment; Testosterone; Treatment Outcome | 2013 |
Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: a randomised controlled study.
Topics: Adult; Aged; Aging; Androgens; Bilirubin; Blood Glucose; Double-Blind Method; Fasting; Hemoglobins; Humans; Injections, Intramuscular; Kallikreins; Lipids; Malaysia; Male; Middle Aged; Physical Examination; Prostate-Specific Antigen; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2013 |
Effect of testosterone treatment on constitutional and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial.
Topics: Adult; Aged; Aging; Androgens; Depression; Diabetes Mellitus, Type 2; Double-Blind Method; Erectile Dysfunction; Hormone Replacement Therapy; Humans; Libido; Male; Middle Aged; Obesity; Placebos; Testosterone; Treatment Outcome | 2014 |
Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadism.
Topics: Administration, Oral; Aged; Aging; Androgens; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypogonadism; Lower Urinary Tract Symptoms; Male; Middle Aged; Prostatic Hyperplasia; Testosterone | 2015 |
Decline of plasma 5alpha-dihydrotestosterone (DHT) levels upon testosterone administration to elderly men with subnormal plasma testosterone and high DHT levels.
Topics: Aging; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Humans; Hypogonadism; Male; Middle Aged; Testosterone | 2008 |
Effect of long-acting testosterone undecanoate treatment on quality of life in men with testosterone deficiency syndrome: a double blind randomized controlled trial.
Topics: Adult; Aging; Analysis of Variance; Androgens; Double-Blind Method; Humans; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Testosterone | 2012 |
Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging.
Topics: Aged; Aging; Carnitine; Climacteric; Depression; Drug Therapy, Combination; Erectile Dysfunction; Fatigue; Humans; Male; Middle Aged; Placebos; Prostate; Prostate-Specific Antigen; Testosterone; Testosterone Congeners; Treatment Outcome | 2004 |
Comparison of effects of the rise in serum testosterone by raloxifene and oral testosterone on serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aging; Double-Blind Method; Estrogen Antagonists; Female; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Male; Middle Aged; Multivariate Analysis; Raloxifene Hydrochloride; Testosterone; Transsexualism | 2005 |
Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.
Topics: Activities of Daily Living; Aged; Aging; Blood Glucose; Body Composition; Bone Density; Cognition; Double-Blind Method; Humans; Insulin Resistance; Lipids; Male; Metabolic Syndrome; Middle Aged; Muscle Strength; Quality of Life; Testosterone | 2008 |
11 other study(ies) available for testosterone undecanoate and Aging
| Article | Year |
|---|---|
Testosterone ameliorates vascular aging via the Gas6/Axl signaling pathway.
Topics: Age Factors; Aging; Animals; Aorta; Arterial Pressure; Axl Receptor Tyrosine Kinase; Carotid Arteries; Cellular Senescence; Fibrosis; Forkhead Box Protein O1; Intercellular Signaling Peptides and Proteins; Male; Mice, Knockout; Phosphorylation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor Protein-Tyrosine Kinases; Signal Transduction; Testosterone; Vascular Remodeling; Vascular Stiffness | 2020 |
Exogenous testosterone alleviates cardiac fibrosis and apoptosis via Gas6/Axl pathway in the senescent mice.
Topics: Aging; Animals; Apoptosis; Fibrosis; Heart; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; Random Allocation; Signal Transduction; Testosterone; Tumor Protein, Translationally-Controlled 1 | 2019 |
Waist circumference is superior to weight and BMI in predicting sexual symptoms, voiding symptoms and psychosomatic symptoms in men with hypogonadism and erectile dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Aging; Androgens; Body Mass Index; Body Weight; Cardiovascular Diseases; Erectile Dysfunction; Follow-Up Studies; Humans; Hypogonadism; Male; Middle Aged; Obesity; Prospective Studies; Quality of Life; Reproductive Health; Risk Factors; Surveys and Questionnaires; Testosterone; Waist Circumference; Young Adult | 2017 |
Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate.
Topics: Adult; Aged; Aging; Androgens; Body Mass Index; C-Reactive Protein; Cohort Studies; Fatty Liver; Humans; Hypogonadism; Liver; Male; Metabolic Syndrome; Middle Aged; Testosterone | 2010 |
Testosterone, tissue factor inhibition and vascular aging.
Topics: Aging; Androgens; Blood Coagulation; Hormone Replacement Therapy; Humans; Lipoproteins; Male; Testosterone; Thromboplastin | 2010 |
[The influence of partial androgen deficiency of aging men (PADAM) on the impulse regime of incretion of several hormones and mitotic activity].
Topics: Adult; Aged; Aging; Androgens; Andropause; Follicle Stimulating Hormone; Growth Hormone; Humans; Insulin; Luteinizing Hormone; Male; Metabolic Syndrome; Middle Aged; Testosterone; Testosterone Congeners | 2006 |
[Testosterone's role in regulating expression of genes of several proliferation factors].
Topics: Actins; Aged; Aging; Androgens; Andropause; Blood Cells; Cell Proliferation; Epidermal Growth Factor; Gene Expression; Genes, bcl-2; Humans; Male; Metabolic Diseases; Metabolic Syndrome; Middle Aged; Receptor, Insulin; Receptors, Estrogen; Receptors, Fibroblast Growth Factor; Testosterone; Testosterone Congeners | 2006 |
Clinical experience with the new long-acting injectable testosterone undecanoate. Report on the educational symposium on the occasion of the 5th World Congress on the Aging Male, 9-12 February 2006, Salzburg, Austria.
Topics: Aged; Aging; Clinical Trials as Topic; Delayed-Action Preparations; Drug Administration Schedule; Hormone Replacement Therapy; Humans; Hypogonadism; Injections; Male; Testosterone | 2006 |
Effects of testosterone therapy in older men.
Topics: Aged; Aging; Body Composition; Humans; Male; Muscle Strength; Quality of Life; Testosterone; Testosterone Congeners | 2008 |
Oral testosterone undecanoate in the management of delayed puberty in boys: pharmacokinetics and effects on sexual maturation and growth.
Topics: Administration, Oral; Adolescent; Aging; Biological Availability; Body Height; Bone and Bones; Dihydrotestosterone; Estradiol; Growth; Humans; Luteinizing Hormone; Male; Puberty, Delayed; Saliva; Sex Hormone-Binding Globulin; Sexual Maturation; Testosterone; Time Factors | 1992 |
[The male climacteric. Endocrinologic profile and therapeutic prospectives].
Topics: Aging; Androgens; Chemical Phenomena; Chemistry; Climacteric; Ejaculation; Humans; Hypothalamo-Hypophyseal System; Male; Sex Hormone-Binding Globulin; Spermatogenesis; Testosterone | 1985 |